You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
潤達醫療(603108.SH)擬延長公開發行可轉債方案決議有效期
格隆匯 03-06 16:50

格隆匯3月6日丨潤達醫療(603108.SH)公佈,公司召開第四屆董事會第三次會議,會議審議並通過《關於延長公開發行可轉換公司債券方案決議有效期的議案》。

公司於2019年3月18日召開2019年第一次臨時股東大會,審議批准了《關於公司2019年公開發行可轉換公司債券方案的議案》等與公司公開發行可轉換公司債券相關議案。前述議案的有效期為自公司2019年第一次臨時股東大會審議通過之日起12個月。公司此次公開發行可轉換公司債券正處於中國證券監督管理委員會審核階段,目前尚未完成發行。

鑑於此次公開發行可轉換公司債券的股東大會決議有效期即將到期,為保持此次公開發行可轉換公司債券工作的延續性和有效性,確保此次發行有關事宜的順利進行,公司董事會提請將公開發行可轉換公司債券股東大會決議有效期延長至自前次決議有效期屆滿之日起十二個月,即2021年3月18日。

除上述延長決議有效期及經第四屆董事會第二次會議審議通過的《關於提請股東大會繼續授權董事會全權辦理此次公開發行可轉換公司債券具體事宜的議案》,此次公開發行可轉換公司債券方案其他事項和內容及其他授權事宜保持不變。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account